In pharmaceutical formulation, are large quantities of a drug substance (usually in powder or liquid form) that have not yet been divided into individual unit doses like tablets or capsules. The "Bulked Up" phase of development often involves transitioning from small-scale laboratory prototypes to a robust, scalable manufacturing process—a stage often governed by detailed regulatory GUI (Guidance) documents. Key Components of Bulk Dosage Development
: Bulk materials use fillers, binders, and lubricants to improve flow and compressibility. For example, ResearchGate articles highlight that choosing the right grade of excipient prevents physical incompatibility and product degradation. Dosages Bulked Up GUI
: Before compression, bulk powders are tested for their "angle of repose" and "tapped density" to ensure they move smoothly through high-speed manufacturing equipment without clogging. Regulatory & Quality Framework (GUI) In pharmaceutical formulation, are large quantities of a
Guide to validation – drugs and supporting activities (GUI-0029) : The Active Pharmaceutical Ingredient (API) is the
Official guidance documents, such as those from Health Canada (GUI-0001) or ZAMRA , outline the standards for bulk drug handling:
Designing an effective bulk formulation requires balancing chemical stability with physical handling properties.
: The Active Pharmaceutical Ingredient (API) is the core of the medicine. Its concentration in bulk mixes must be strictly monitored to ensure each final unit dose is accurate.